Research - Melbourne, Victoria, Australia
Drawbridge is a privately-held company head quartered in Melbourne, Australia. Drawbridge is developing neuroactive steroid compounds for use in critical care situations in which protection of the brain from insult is required. Phaxan™ is the lead compound for use as a fast onset and offset intravenous general anaesthetic and sedative that causes neuroprotection.
reCAPTCHA
ASP.NET
Outlook
Google Font API
Microsoft Office 365
GoDaddy Hosting